User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis

Journal of Travel Medicine

Volumn 3, Issue 1, 1996, Pages 40-45

  Phillips, Margaret A ^a,b   Kass, Robert B ^a  

^a Traveller's Med Vaccination Ctr   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002181449     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1996.tb00695.x     Document Type: Article

References (13)

1. World Health Organization. Malaria chemoprophylaxis regimens for travellers. Wkly Epidemiol Rec 1993; 51:377-383.
2. NHMRC. Report of the NHMRC Public Health Committee: Malaria Prophylaxis. Canberra:Australian Government Publishing Service, 1993.
3. Kando JC, Yonkers KA, Cole JO. Gender as a risk factor for adverse events to medications. Drugs 1995; 50:1-6.
4. Phillips M. Antimalarial mefloquine. (Letter to the Editor.) Med J Aust 1994; 161:227.
5. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993; 341:1299-1305.
6. Fine PEM, Chen RT. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol 1992; 136:121-135.
7. Davies DM. Textbook of adverse drug reactions. 4th Ed. Oxford: Oxford University Press, 1991.
8. Macleod SM, Giles HG, Bengert B, et al. Age and gender related differences in diazepam pharmacokinetics. J Clin Pharmac 1979; 19:15-19.
9. Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992; 44:275-283.
10. Karbwang J, Bunnag D, Breckenridge AM, et al. The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects. Eur J Clin Pharmacol 1987; 32: 173-177.
11. Wittes RC, Saginur R. Adverse reaction to mefloquine associated with ethanol ingestion. Can Med Assoc J 1995; 152:515-517.
12. Lobel HO, Miani M, Eng T, et al. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341:848-885.
13. Behrens RH, Roberts JA. Is travel prophylaxis worthwhile? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ 1994; 309:918-922.